Maccabi becomes the 1st HMO to add MeMed BV® test for routine care
Category: #health  | By Nikita Chaurasia  | Date: 2022-06-08 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Maccabi becomes the 1st HMO to add MeMed BV® test for routine care

After successfully receiving the US FDA (Food and Drug Administration) clearance for the MeMed BV® test, which helps physicians to differentiate between viral and bacterial infection in only 15 minutes, Maccabi Healthcare Services has announced that it is unveiling the test in all its urgent care centers located in Israel. 

Through this latest accomplishment, Maccabi, one of the major health maintenance organizations (HMOs) around the globe, becomes the first global HMO to include the test in routine care.

Dr. Miri Mizrahi Reuven, Head of Maccabi's health division, said that this new test is a revolutionary technology that will empower a rapid and more accurate diagnosis in community medicine.

The test is projected for use in cases where healthcare professionals are unsure if it originates from a viral or bacterial infection and when the typical auxiliary tests are not adequate.

It also offers major benefits for children and older population who normally possess a high risk of medical weakening if the bacterial infection is not treated within the given timeframe.

The firm believes that this test will prove to be a life savior.

The MeMed BV test is inbuilt on a technology that deciphers the body's immune response to infection, the host response, instead of emphasizing on the detection of the microbe presence.

This results in sturdy diagnosis when the infection site is unknown or inaccessible, even when the pathogen is untraceable using conventional tests, or at the time when the infections are caused because of emerging new pathogens.

The MeMed BV® test allows doctors to take accurate antibiotic treatment decisions and is a very important tool that can be used to fight against impervious bacteria.

As per credible sources, Maccabi Healthcare Services is planning to make the technology available in all the urgent care centers of the organizations starting this month.

Source Credit - https://www.globenewswire.com/news-release/2022/06/07/2457291/0/en/Maccabi-Healthcare-Services-announces-it-is-the-first-HMO-in-the-world-to-include-MeMed-BV-test-as-part-of-routine-care.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Vietnam extends COVID-19 vaccine coverage to 12 years old and above

Vietnam extends COVID-19 vaccine coverage to 12 years old and above

By Nikita Chaurasia

Pham Minh Chính, Prime Minister of Vietnam, is prompting the Ministry of Health and local authorities to amplify the administration of third and fourth COVID-19 vaccine doses for individuals aged 12 years and above. If sources are to be bel...

Samsung kickstarts chip production with 3nm process technology

Samsung kickstarts chip production with 3nm process technology

By Nikita Chaurasia

Samsung Electronics Co Ltd has reportedly declared that it has begun the mass production of chips using advanced 3-nanometre technology. The company is the first in the entire world to do so and is actively looking for new clients to contest with Tai...

Progcap nabs $40Mn in funding round for expansion & product development

Progcap nabs $40Mn in funding round for expansion & product development

By Nikita Chaurasia

Progcap, a pioneer in the field of corporate-driven financing solutions for small and medium-sized businesses (SMBs), has secured $40 million in private equity capital at $600 million valuation. The raised capital forms a part of the Series C exte...